Sandoz Group AG (Sandoz Group AG) Days Sales Outstanding : 22.05 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Days Sales Outstanding?

Sandoz Group AG's average Accounts Receivable for the three months ended in Dec. 2023 was $2,411 Mil. Sandoz Group AG's Revenue for the three months ended in Dec. 2023 was $9,979 Mil. Hence, Sandoz Group AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 22.05.

The historical rank and industry rank for Sandoz Group AG's Days Sales Outstanding or its related term are showing as below:

SDZNY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 86.56 Med: 88.93 Max: 91.3
Current: 91.3

During the past 2 years, Sandoz Group AG's highest Days Sales Outstanding was 91.30. The lowest was 86.56. And the median was 88.93.

SDZNY's Days Sales Outstanding is ranked worse than
67.84% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs SDZNY: 91.30

Sandoz Group AG's Days Sales Outstanding increased from . 20 (0.00) to Dec. 2023 (22.05).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Sandoz Group AG Days Sales Outstanding Historical Data

The historical data trend for Sandoz Group AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Days Sales Outstanding Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Days Sales Outstanding

86.56

88.19

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Days Sales Outstanding	21.64	22.05

Competitive Comparison of Sandoz Group AG's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Days Sales Outstanding falls into.

Sandoz Group AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sandoz Group AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2207	+	2615)	/	2 )	/	9979	*	365
=	2411					/	9979	*	365
=	88.19

Sandoz Group AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2207	+	2615)	/	2 )	/	9979	*	365 / 4
=	2411					/	9979	*	365 / 4
=	22.05

Sandoz Group AG (OTCPK:SDZNY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sandoz Group AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024